436 research outputs found
Safety of endoscopic procedures after acute myocardial infarction: A systematic review
Background: The management of patients who develop gastrointestinal (GI) bleeding after
acute myocardial infarction (MI) is difficult due to concerns about possible cardiovascular
complications. Gastroenterologists are often reluctant to perform endoscopic procedures despite
urgent indications. We performed a systematic review of the literature to determine the safety
of endoscopic procedures after MI.
Methods: We searched MEDLINE, EMBASE and the Cochrane Central Register of
Controlled trials for controlled clinical trials or case series examining the diagnostic efficacy
and complications of esophagogastroduodenoscopy (EGD), colonoscopy and flexible sigmoidoscopy
after MI. Title and abstract screening was followed by full-text review with subsequent
data extraction of included studies.
Results: A total of seven studies met inclusion criteria. Four studies evaluated safety and
efficacy of EGD after MI. The reported complication rate ranged between 1-8%, with a large
predominance of minor complications. We found one study addressing safety of flexible
sigmoidoscopy that reported minor complications in two patients. We also identified one study
addressing the safety of colonoscopy after MI, which showed a complication rate of 9%. Most of
these complications were minor. A decision analysis was also included in this review.
Conclusions: Our review demonstrated that endoscopic procedures are safe and beneficial in
stable patients with GI bleeding after recent MI and should be performed without a requisite
delay. Unstable patients should undergo endoscopic procedures only in the intensive care
setting, after stabilization and with close monitoring. (Cardiol J 2012; 19, 5: 447-452
The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity.
Purpose: A multifold association relates the hypothalamo-pituitary-thyroid axis to body weight. The potential underlying mechanisms are incompletely understood. Further, the mild severity of obesity and the small proportion of individuals with obesity in so far published cohort studies provide little insights on metabolic correlates of thyroid function in obesity. Methods: We retrospectively enrolled 5009 adults with obesity (F/M, 3448/1561; age range, 18-87 years; BMI range, 30.0-82.7 kg/m2), without known thyroid disease in a study on TSH and fT4 levels, lipid profile, glucose homeostasis and insulin resistance, anthropometric parameters including BIA-derived fat mass (%FM) and fat-free mass (FFM). Results: The overall reference interval for TSH in our obese cohort was 0.58-5.07 mIU/L. As subgroups, females and non-smokers showed higher TSH levels as compared to their counterparts (p<0.0001 for both), while fT4 values were comparable between groups. There was a significant upward trend for TSH levels across incremental BMI classes in females, while the opposite trend was seen for fT4 levels in males (p<0.0001 for both). Expectedly, TSH was associated with %FM and FFM (p<0,0001 for both). TSH and fT4 showed correlations with several metabolic variables, and both declined with aging (TSH, p<0.0001; fT4, p<0.01). In a subgroup undergoing leptin measurement, leptin levels were positively associated with TSH levels (p<0.01). At the multivariable regression analysis, in the group as a whole, smoking habit emerged as the main independent predictor of TSH (β=-0.24, p<0.0001) and fT4 (β=-0.25, p<0.0001) levels. In non-smokers, %FM (β=0.08, p<0.0001) and age (β=-0.05, p<0.001) were the main significant predictors of TSH levels. In the subset of nonsmokers having leptin measured, leptin emerged as the strongest predictor of TSH levels (β=0.17, p<0.01). Conclusions: Our study provides evidence of a gender- and smoking-dependent regulation of TSH levels in obesity
- …